MAP1LC3A and myositis disease: Interestingly, LAMP2 and LC3 expression in the anti-Ku-positive group tended to be the highest, suggesting that lysosomal degradation disorders may contribute to anti-Ku-associated myositis, distinguishing it from sIBM.